Gansevoort RT - Search Results

1

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Nephrol Dial Transplant. 1995;10(4):497-504. doi: 10.1093/ndt/10.4.497. Nephrol Dial Transplant. 1995. PMID: 7623991 Clinical Trial.

2

Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe-lessons for the future.

Noordzij M, Meijers B, Gansevoort RT, Covic A, Duivenvoorden R, Hilbrands LB, Hemmelder MH, Jager KJ, Mjoen G, Nistor I, Parshina E, Pessolano G, Tuglular S, Vart P, Zanoli L, Franssen CFM; ERACODA collaborators. Noordzij M, et al. Among authors: gansevoort rt. Clin Kidney J. 2022 Dec 2;16(4):662-675. doi: 10.1093/ckj/sfac253. eCollection 2023 Apr. Clin Kidney J. 2022. PMID: 37007687 Free PMC article. Review.

3

Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.

Bouwmans P, Messchendorp AL, Imhof C, Sanders JF, Hilbrands LB, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel RMA, Ten Dam MAGJ, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH; RECOVAC Collaborators. Bouwmans P, et al. Among authors: gansevoort rt. Clin Kidney J. 2022 Nov 24;16(3):528-540. doi: 10.1093/ckj/sfac249. eCollection 2023 Mar. Clin Kidney J. 2022. PMID: 36865021 Free PMC article.

4

Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.

Gansevoort RT, Heeg JE, Vriesendorp R, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Nephrol Dial Transplant. 1992;7 Suppl 1:91-6. Nephrol Dial Transplant. 1992. PMID: 1337189

5

The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.

Gansevoort RT, Apperloo AJ, Heeg JE, de Jong PE, de Zeeuw D. Gansevoort RT, et al. Arch Intern Med. 1992 Oct;152(10):2137-9. Arch Intern Med. 1992. PMID: 1417388 No abstract available.

6

Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.

Gansevoort RT, Wapstra FH, Weening JJ, de Jong PE, de Zeeuw D. Gansevoort RT, et al. Nephron. 1992;60(2):246-7. doi: 10.1159/000186753. Nephron. 1992. PMID: 1553017 Free article. No abstract available.

7

Losartan in patients with renal insufficiency.

de Zeeuw D, Gansevoort RT, de Jong PE. de Zeeuw D, et al. Among authors: gansevoort rt. Can J Cardiol. 1995 Aug;11 Suppl F:41F-44F. Can J Cardiol. 1995. PMID: 7664217

8

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE. Gansevoort RT, et al. J Hypertens Suppl. 1994 Jul;12(2):S37-42. J Hypertens Suppl. 1994. PMID: 7965264 Clinical Trial.

9

Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.

Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP. Gansevoort RT, et al. Nephrol Dial Transplant. 1994;9(3):244-50. Nephrol Dial Transplant. 1994. PMID: 8052429

10

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113. Kidney Int. 1994. PMID: 8196289 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters